71 results
DEFR14A
GTBP
GT Biopharma Inc
5 May 23
Revised proxy
5:28pm
and delivering those materials and reducing the environmental impact of our Annual Meeting. However, if you would prefer to receive printed proxy materials
8-K
EX-10.2
x6wa6c32sy3k
9 Feb 21
Entry into a Material Definitive Agreement
12:00am
424B3
u09vns7y7lee2m
9 Nov 20
Prospectus supplement
5:01pm
8-K
EX-10.1
obqdr3h4c
9 Nov 20
Entry into a Material Definitive Agreement
4:46pm
424B3
672fac94v
22 Sep 20
Prospectus supplement
4:46pm
8-K
EX-10.1
qgl8f
22 Sep 20
Entry into a Material Definitive Agreement
4:02pm
D/A
a6fdlz4x8bgiy
23 Jul 20
Indefinite amount in debt / Debt convertible into equity., sold $5.61M, 18 investors
5:00pm
8-K
EX-10.1
6g19 fo3wtaq3ub
9 Jul 20
Entry into a Material Definitive Agreement
4:16pm
D
0zvw0z 61rno
12 Jun 20
Indefinite amount in debt / Debt convertible into equity, sold $2.42M, 9 investors
4:46pm